Abstract
Background: Knee osteoarthritis (KOA) is currently treated by regenerative therapies that aim to inhibit arthritic degeneration. Extracorporeal shock wave therapy (ESWT) is one of the physical regenerative approaches used for KOA management. However, little is known regarding the impact of shock wave treatment on matrix metalloproteinase-3 (MMP-3), which is one of the enzymes mediating cartilage degradation.
Objectives: To evaluate the effect of ESWT on MMP-3 levels and pain intensity in patients with KOA.
Methods: Fourteen patients diagnosed with Kellgren Lawrence, grades 2 and 3 KOA were recruited for the study. ESWT piezo shockwave was applied once a week for six weeks. MMP-3 levels in the blood were measured pre-test, mid-test (three weeks after therapy) and post-test (one week after the last session) by enzyme-linked immunosorbent assay (ELISA). The perceived pain was recorded at each session by the Wong Becker Face Scale.
Results: The median pre-test, mid-test and post-test MMP-3 levels were 19.92 ng/mL, 15.89 ng/mL and 18.82 ng/mL, respectively, and there were significant differences between the pre-test and mid-test, and the pre-test and post-test values (p < 0.05). The pain scores also decreased significantly over the period of intervention.
Conclusion: MMP-3 levels decreased significantly in KOA patients after ESWT, and the decline was most obvious after 3 weeks of therapy. Therefore, EWST should be considered as a suitable treatment option for KOA.
Graphical Abstract
[1]
Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 2020; 29-30: 100587.
[http://dx.doi.org/10.1016/j.eclinm.2020.100587] [PMID: 34505846]
[http://dx.doi.org/10.1016/j.eclinm.2020.100587] [PMID: 34505846]
[2]
van Tunen JAC, Dell’Isola A, Juhl C, et al. Association of malalignment, muscular dysfunction, proprioception, laxity and abnormal joint loading with tibiofemoral knee osteoarthritis: A systematic review and meta-analysis. BMC Musculoskelet Disord 2018; 19(1): 273.
[http://dx.doi.org/10.1186/s12891-018-2202-8] [PMID: 30055600]
[http://dx.doi.org/10.1186/s12891-018-2202-8] [PMID: 30055600]
[3]
Alisiya A, Sulistiawati S, Kurniawati PM, Wardhani RRIL. Risk factors of body mass index (BMI), age of menarche, parity and hormonal contraception of genu osteoarthritis in female patients. Folia Medica Indonesiana 2021; 57(2): 104.
[http://dx.doi.org/10.20473/fmi.v57i2.23029]
[http://dx.doi.org/10.20473/fmi.v57i2.23029]
[4]
Susanti A, Wardhani RIL, Pawana IPA. Relationship between quadriceps muscle atrophy and proprioception function in knee osteoarthritis patients 2019; 2: 6.
[5]
Kolasinski SL, Neogi T, Hochberg MC, et al. American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol 2020; 72(2): 220-33.
[http://dx.doi.org/10.1002/art.41142] [PMID: 31908163]
[http://dx.doi.org/10.1002/art.41142] [PMID: 31908163]
[6]
Gönen C, Yalın C. Long-term efficiency of extracorporeal shockwave therapy on lateral epicondylitis. Acta Orthop Belg 2017; 83(3): 438-44.
[7]
Rini LA, Damayanti T. The effect of dexterity and perturbation exercise on knee osteoarthritis through functional balance and power improvement of quadriceps and hamstring. IJFMT 2020. Available From: http://medicopublication.com/index.php/ijfmt/article/ view/3372(Accessed on 2022 Sep 28).
[8]
Haake M, Böddeker I, Decker T, et al. Side-effects of extracorporeal shock wave therapy (ESWT) in the treatment of tennis elbow. Arch Orthop Trauma Surg 2002; 122(4): 222-8.
[http://dx.doi.org/10.1007/s00402-001-0362-7] [PMID: 12029512]
[http://dx.doi.org/10.1007/s00402-001-0362-7] [PMID: 12029512]
[9]
Xie X, Zhu J, Zhang H. Effects of extracorporeal shock wave therapy in patients with knee osteoarthritis. Medicine 2020; 99(35): e21749.
[http://dx.doi.org/10.1097/MD.0000000000021749] [PMID: 32871895]
[http://dx.doi.org/10.1097/MD.0000000000021749] [PMID: 32871895]
[10]
Xu Y, Wu K, Liu Y, et al. The effect of extracorporeal shock wave therapy on the treatment of moderate to severe knee osteoarthritis and cartilage lesion. Medicine 2019; 98(20): e15523.
[http://dx.doi.org/10.1097/MD.0000000000015523] [PMID: 31096453]
[http://dx.doi.org/10.1097/MD.0000000000015523] [PMID: 31096453]
[11]
Ma H, Zhang W, Shi J, Zhou D, Wang J. The efficacy and safety of extracorporeal shockwave therapy in knee osteoarthritis: A systematic review and meta-analysis. Int J Surg 2020; 75: 24-34.
[http://dx.doi.org/10.1016/j.ijsu.2020.01.017] [PMID: 31978648]
[http://dx.doi.org/10.1016/j.ijsu.2020.01.017] [PMID: 31978648]
[12]
Jenei-Lanzl Z, Meurer A, Zaucke F. Interleukin-1β signaling in osteoarthritis: Chondrocytes in focus. Cell Signal 2019; 53: 212-23.
[http://dx.doi.org/10.1016/j.cellsig.2018.10.005] [PMID: 30312659]
[http://dx.doi.org/10.1016/j.cellsig.2018.10.005] [PMID: 30312659]
[13]
Blom AB, van Lent PL, Libregts S, et al. Crucial role of macrophages in matrix metalloproteinase–mediated cartilage destruction during experimental osteoarthritis: Involvement of matrix metalloproteinase 3. Arthritis Rheum 2007; 56(1): 147-57.
[http://dx.doi.org/10.1002/art.22337] [PMID: 17195217]
[http://dx.doi.org/10.1002/art.22337] [PMID: 17195217]
[14]
Lohmander LS, Brandt KD, Mazzuca SA, et al. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheum 2005; 52(10): 3160-7.
[http://dx.doi.org/10.1002/art.21345] [PMID: 16200596]
[http://dx.doi.org/10.1002/art.21345] [PMID: 16200596]
[15]
Mehana ESE, Khafaga AF, El-Blehi SS. The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review. Life Sci 2019; 234: 116786.
[http://dx.doi.org/10.1016/j.lfs.2019.116786] [PMID: 31445934]
[http://dx.doi.org/10.1016/j.lfs.2019.116786] [PMID: 31445934]
[16]
Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: Associations with degenerative changes. Arthritis Rheum 2001; 44(3): 585-94.
[http://dx.doi.org/10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C] [PMID: 11263773]
[http://dx.doi.org/10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C] [PMID: 11263773]
[17]
Wan J, Zhang G, Li X, et al. Matrix metalloproteinase 3: A promoting and destabilizing factor in the pathogenesis of disease and cell differentiation. Front Physiol 2021; 12: 663978.
[http://dx.doi.org/10.3389/fphys.2021.663978] [PMID: 34276395]
[http://dx.doi.org/10.3389/fphys.2021.663978] [PMID: 34276395]
[18]
Chen JJ, Huang JF, Du WX, Tong PJ. Expression and significance of MMP3 in synovium of knee joint at different stage in osteoarthritis patients. Asian Pac J Trop Med 2014; 7(4): 297-300.
[http://dx.doi.org/10.1016/S1995-7645(14)60042-0] [PMID: 24507680]
[http://dx.doi.org/10.1016/S1995-7645(14)60042-0] [PMID: 24507680]
[19]
Ji Q, He C. Extracorporeal shockwave therapy promotes chondrogenesis in cartilage tissue engineering: A hypothesis based on previous evidence. Med Hypotheses 2016; 91: 9-15.
[http://dx.doi.org/10.1016/j.mehy.2016.03.013] [PMID: 27142133]
[http://dx.doi.org/10.1016/j.mehy.2016.03.013] [PMID: 27142133]
[20]
Waugh C, Jones E, Riley G, Langberg H, Morrissey D, Screen H. The effects of extracorporeal shockwave therapy on matrix metalloprotease activity in tendinopathy (1046.8). FASEB J 2014; 28(S1): 1046-8.
[http://dx.doi.org/10.1096/fasebj.28.1_supplement.1046.8]
[http://dx.doi.org/10.1096/fasebj.28.1_supplement.1046.8]
[21]
Wang CJ, Cheng JH, Chou WY, Hsu SL, Chen JH, Huang CY. Changes of articular cartilage and subchondral bone after extracorporeal shockwave therapy in osteoarthritis of the knee. Int J Med Sci 2017; 14(3): 213-23.
[http://dx.doi.org/10.7150/ijms.17469] [PMID: 28367081]
[http://dx.doi.org/10.7150/ijms.17469] [PMID: 28367081]
[22]
Chou WY, Cheng JH, Wang CJ, Hsu SL, Chen JH, Huang CY. Shockwave targeting on subchondral bone is more suitable than articular cartilage for knee osteoarthritis. Int J Med Sci 2019; 16(1): 156-66.
[http://dx.doi.org/10.7150/ijms.26659] [PMID: 30662339]
[http://dx.doi.org/10.7150/ijms.26659] [PMID: 30662339]
[23]
Avendaño-Coy J, Comino-Suárez N, Grande-Muñoz J, Avendaño-López C, Gómez-Soriano J. Extracorporeal shockwave therapy improves pain and function in subjects with knee osteoarthritis: A systematic review and meta-analysis of randomized clinical trials. Int J Surg 2020; 82: 64-75.
[http://dx.doi.org/10.1016/j.ijsu.2020.07.055] [PMID: 32798759]
[http://dx.doi.org/10.1016/j.ijsu.2020.07.055] [PMID: 32798759]
[24]
Simplicio CL, Purita J, Murrell W, Santos GS, dos Santos RG, Lana JFSD. Extracorporeal shock wave therapy mechanisms in musculoskeletal regenerative medicine. J Clin Orthop Trauma 2020; 11 (3): S309-18.
[http://dx.doi.org/10.1016/j.jcot.2020.02.004] [PMID: 32523286]
[http://dx.doi.org/10.1016/j.jcot.2020.02.004] [PMID: 32523286]
[25]
Wang YC, Huang HT, Huang PJ, Liu ZM, Shih CL. Efficacy and safety of extracorporeal shockwave therapy for treatment of knee osteoarthritis: A systematic review and meta-analysis. Pain Med 2020; 21(4): 822-35.
[http://dx.doi.org/10.1093/pm/pnz262] [PMID: 31626282]
[http://dx.doi.org/10.1093/pm/pnz262] [PMID: 31626282]
[26]
Subadi I, Nugraha B, Laswati H, Josomuljono H. Pain relief with wet cupping therapy in rats is mediated by heat shock protein 70 and ß-Endorphin. Iran J Med Sci 2017; 42(2): 384-91.
[27]
Schmitz C, DePace R. Pain relief by extracorporeal shockwave therapy: an update on the current understanding. Urol Res 2009; 37(4): 231-4.
[http://dx.doi.org/10.1007/s00240-009-0190-8] [PMID: 19444437]
[http://dx.doi.org/10.1007/s00240-009-0190-8] [PMID: 19444437]
[28]
Li W, Pan Y, Yang Q, Guo Z, Yue Q, Meng QG. Extracorporeal shockwave therapy for the treatment of knee osteoarthritis. Medicine 2018; 97(27): e11418.
[http://dx.doi.org/10.1097/MD.0000000000011418] [PMID: 29979441]
[http://dx.doi.org/10.1097/MD.0000000000011418] [PMID: 29979441]
Related Books
Natural Products for the Management of Arthritic Disorders
